In Brief: (Mis)splicing in disease

Journal of Pathology

Volumn 233, Issue 1, 2014, Pages 1-3

  Pedrotti, Simona ^a   Cooper, Thomas A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cancer; myelodysplastic syndromes; spliceosomal mutations; splicing

Indexed keywords

MESSENGER RNA PRECURSOR;

ARTICLE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; MOLECULARLY TARGETED THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RNA SPLICING; SPLICEOSOME; SPLICING DEFECT;

CANCER; MYELODYSPLASTIC SYNDROMES; SPLICEOSOMAL MUTATIONS; SPLICING;

GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; PHENOTYPE; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER;

EID: 84898463995     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4337     Document Type: Article

References (7)

1. Hoskins AA, Moore MJ,. The spliceosome: a flexible, reversible macromolecular machine. Trends Biochem Sci 2012; 37: 179-188.
2. Black DL,. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336. (Pubitemid 36930448)
3. Ward AJ, Cooper TA,. The pathobiology of splicing. J Pathol 2010; 220: 152-163.
4. Cartegni L, Chew SL, Krainer AR,. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285-298. (Pubitemid 34279797)
5. Yoshida K, Sanada M, Shiraishi Y, et al., Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
6. Papaemmanuil E, Cazzola M, Boultwood J, et al., Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365: 1384-1395.
7. Corey SJ, Minden MD, Barber DL, et al., Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007; 7: 118-129. (Pubitemid 46164747)